Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease

Abstract

Gastrointestinal symptoms such as abdominal pain, dyspepsia, and diarrhea are relatively nonspecific and a common cause for seeking medical attention. To date, it is challenging for physicians to differentiate between functional and organic gastrointestinal conditions and it involves the use of serological and endoscopic techniques. Therefore, a simple, noninvasive, inexpensive, and effective test would be of utmost importance in clinical practice. Fecal calprotectin (FC) is considered to be a reliable biomarker that fulfills these criteria. FC can detect intestinal inflammation, and its level correlates well with macroscopic and histological inflammation as detected by colonoscopy and biopsies, respectively. FC has a decent diagnostic accuracy for differentiating organic diseases and functional disorders because of its excellent negative predictive value in ruling out inflammatory bowel disease (IBD) in symptomatic undiagnosed patients. There is accumulating evidence that FC has been effectively used to monitor the natural course of IBD, to predict relapse, and to see the response to treatment. This novel biomarker has the ability to assess mucosal healing (MH), which is a therapeutic goal in IBD management. A literature search was carried out using PubMed with the keywords FC, IBD, intestinal inflammation, and MH. In our review, we provide an overview of the utility and scope of FC as a biomarker in patients with IBD as well as undiagnosed patients with lower gastrointestinal symptoms.

S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy

“…S100A8/A9 is a critical player during inflammatory responses . Previous studies have shown that, in human diseases, S100A8/A9 can be detected in serum, aspirates or faeces of patients with rheumatoid arthritis , acute rejection , inflammatory bowel disease , lung disease , systemic sclerosis and atherosclerosis . In the context of renal fibrosis, we are the first to show that S100A8/A9 expression is increased in patients with obstructive nephropathy and localizes uniquely to interstitial granulocytes and not to other parenchymal cells, such as epithelial cells .…”

Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units

“…One of the advantages of our classification algorithm is that only 4 molecules comprise the panel, and 2 of them are already established in hospitals: CEA is routinely measured for various types of tumours, while CAL is also quantified for its utility in inflammatory colon processes33. This makes our 4-marker panel simple and affordable to guide clinical decision-making and complement CT scan.…”

A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers

“…The most widely used blood markers for IBD have been C reactive protein (CRP) and erythrocyte sedimentation rate (ESR) but leukocyte count, albumin, and α1 acid glycoprotein have also been used . Fecal calprotectin was introduced approximately two decades ago as a marker of inflammatory bowel disease, and has over the years been shown to have a higher sensitivity and specificity for IBD than ESR . Fecal calprotectin is mainly released from granulocytes in inflamed areas in the gut .…”